3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Multiple Myeloma
5
Prostatic Neoplasms
3
Recurrence
2
Neoplasm Metastasis
2
Breast Neoplasms
2
Waldenstrom Macroglobulinemia
1
Solid Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell
1
Lymphoma
1
Lung Neoplasms
1
Leukemia
1
Immunoblastic Lymphadenopathy
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Head and Neck Fibrosis
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Solid Tumors
1
Advanced Non-Small Cell Lung Cancer
1
Interventions
alpha-Tocopherol
1
WW Domain-Containing Oxidoreductase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Head and Neck Fibrosis
×
WW Domain-Containing Oxidoreductase
×
Clear all
NCT03723291
2026-03-03
PITSTOP
University College, London
Phase 1
Completed
50 enrolled